OptimizeRx OPRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70%+2.8pp | 67.3%+1.9pp | 65.3%+0.9pp | 64.4%+8.5pp | 55.9%+15.6pp | |
| Net margin | 6.4%+1.7pp | 4.7%+4.7pp | 0%+9.5pp | -9.4%+10.7pp | -20.1%+16.6pp | |
| Returns | ||||||
| Return on equity | 5.6%+1.4pp | 4.2%+4.2pp | 0%+8.2pp | -8.2%+4.7pp | -12.9%+3.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.7×0.0× | 0.6×+0.2× | 0.4×+0.1× | |
| Liquidity | ||||||
| Current ratio | 5.4×+2.3× | 3×0.0× | 3×+0.5× | 2.6×-0.2× | 2.8×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.3×0.0× | |
| Per Share | ||||||
| Book value per share | $6.91+2.3% | $6.75+7.5% | $6.28+0.2% | $6.27-0.3% | $6.29-1.6% | |
| Valuation | ||||||
| Market capitalization | $107.34M-54.1% | $228.53M-40.0% | $380.58M+59.5% | $238.59M+49.0% | $160.13M+78.9% | |
| Price / sales | 1×-1.2× | 2.1×-1.4× | 3.5×+1.2× | 2.3×+0.2× | 2.1×+0.5× | |
| Price / book | 0.8×-1.1× | 1.8×-1.3× | 3.1×+1.1× | 2×+0.6× | 1.4×+0.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are OptimizeRx's profit margins?
- OptimizeRx (OPRX) runs a 70.0% gross margin and a 13.2% operating margin, with a 6.4% net margin.
- Where do OptimizeRx's ratios come from?
- Every ratio is computed from OptimizeRx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
